In liver cancer, particularly hepatocellular carcinoma (HCC), FGF19 is found to be notably overexpressed in approximately 5–10% of HCC cases, which implies that FGF signaling plays a crucial role in tumor progression [99]. Here, FGF19 is linked to neoplasm.